Dr. Reddy's Laboratories Ltd ADR (RDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Sales | 543,085 | 543,000 | 524,894 | 589,930 | 553,176 |
| Cost of Goods | 244,258 | 241,000 | 243,620 | 258,060 | 258,320 |
| Gross Profit | 298,827 | 303,000 | 280,274 | 331,871 | 294,856 |
| Operating Expenses | 226,928 | 234,000 | 241,938 | 254,291 | 235,771 |
| Operating Income | 72,158 | 70,000 | 38,956 | 77,640 | 59,405 |
| Interest Expense | 2,974 | 3,000 | 3,390 | 3,131 | 3,479 |
| Other Income | 13,471 | 6,000 | 19,821 | 17,639 | 4,540 |
| Pre-tax Income | 82,654 | 73,000 | 55,387 | 92,148 | 60,466 |
| Income Tax | 10,611 | 7,000 | 10,663 | 40,316 | 16,021 |
| Net Income Continuous | 72,043 | 66,000 | 44,724 | 51,832 | 44,444 |
| Net Income | $72,043 | $67,000 | $45,724 | $51,832 | $44,444 |
| EPS Basic Total Ops | 0.09 | 0.08 | 0.05 | 0.06 | 0.05 |
| EPS Basic Continuous Ops | 0.09 | 0.08 | 0.05 | 0.06 | 0.05 |
| EPS Diluted Total Ops | 0.09 | 0.08 | 0.05 | 0.06 | 0.05 |
| EPS Diluted Continuous Ops | 0.09 | 0.08 | 0.05 | 0.06 | 0.05 |
| EBITDA(a) | $110,158 | $112,000 | $83,956 | $125,640 | $104,405 |